Co­di­ak files for an IPO, again, this time shoot­ing for a nine-dig­it raise

Sec­ond time’s the charm?

Co­di­ak Bio­sciences is fil­ing for an IPO once again, sub­mit­ting pa­per­work Wednes­day, af­ter back­ing out of its pre­vi­ous at­tempt in Ju­ly 2019 due to un­fa­vor­able mar­ket con­di­tions. The com­pa­ny is pric­ing in a new raise of $100 mil­lion, up from $86 mil­lion in its ini­tial pur­suit.

There have al­ready been four dozen biotech IPOs so far this year, net­ting the sec­tor more than $11 bil­lion.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER